Cargando…

Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model

BACKGROUND: The therapeutic potential of mesenchymal stem cells (MSCs)-derived conditioned media (CM) can be increased after preconditioning with various chemical agents. The aim of this study is comparative evaluation of effects of N-CM and DFS-CM which are collected from normal (N) and deferoxamin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozkan, Serbay, Isildar, Basak, Ercin, Merve, Gezginci-Oktayoglu, Selda, Konukoglu, Dildar, Neşetoğlu, Neşet, Oncul, Mahmut, Koyuturk, Meral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438289/
https://www.ncbi.nlm.nih.gov/pubmed/36056427
http://dx.doi.org/10.1186/s13287-022-03121-6
_version_ 1784781795937484800
author Ozkan, Serbay
Isildar, Basak
Ercin, Merve
Gezginci-Oktayoglu, Selda
Konukoglu, Dildar
Neşetoğlu, Neşet
Oncul, Mahmut
Koyuturk, Meral
author_facet Ozkan, Serbay
Isildar, Basak
Ercin, Merve
Gezginci-Oktayoglu, Selda
Konukoglu, Dildar
Neşetoğlu, Neşet
Oncul, Mahmut
Koyuturk, Meral
author_sort Ozkan, Serbay
collection PubMed
description BACKGROUND: The therapeutic potential of mesenchymal stem cells (MSCs)-derived conditioned media (CM) can be increased after preconditioning with various chemical agents. The aim of this study is comparative evaluation of effects of N-CM and DFS-CM which are collected from normal (N) and deferoxamine (DFS) preconditioned umbilical cord-derived MSCs on rat diabetic nephropathy (DN) model. METHODS: After incubation of the MSCs in serum-free medium with/without 150 µM DFS for 48 h, the contents of N-CM and DFS-CM were analyzed by enzyme-linked immunosorbent assay. Diabetes (D) was induced by single dose of 55 mg/kg streptozotocin. Therapeutic effects of CMs were evaluated by biochemical, physical, histopathological and immunohistochemical analysis. RESULTS: The concentrations of vascular endothelial growth factor alpha, nerve growth factor and glial-derived neurotrophic factor in DFS-CM increased, while one of brain-derived neurotrophic factor decreased in comparison with N-CM. The creatinine clearance rate increased significantly in both treatment groups, while the improvement in albumin/creatinine ratio and renal mass index values were only significant for D + DFS-CM group. Light and electron microscopic deteriorations and loss of podocytes-specific nephrin and Wilms tumor-1 (WT-1) expressions were significantly restored in both treatment groups. Tubular beclin-1 expression was significantly increased for DN group, but it decreased in both treatment groups. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive apoptotic cell death increased in the tubules of D group, while it was only significantly decreased for D + DFS-CM group. CONCLUSIONS: DFS-CM can be more effective in the treatment of DN by reducing podocyte damage and tubular apoptotic cell death and regulating autophagic activity with its more concentrated secretome content than N-CM. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03121-6.
format Online
Article
Text
id pubmed-9438289
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94382892022-09-03 Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model Ozkan, Serbay Isildar, Basak Ercin, Merve Gezginci-Oktayoglu, Selda Konukoglu, Dildar Neşetoğlu, Neşet Oncul, Mahmut Koyuturk, Meral Stem Cell Res Ther Research BACKGROUND: The therapeutic potential of mesenchymal stem cells (MSCs)-derived conditioned media (CM) can be increased after preconditioning with various chemical agents. The aim of this study is comparative evaluation of effects of N-CM and DFS-CM which are collected from normal (N) and deferoxamine (DFS) preconditioned umbilical cord-derived MSCs on rat diabetic nephropathy (DN) model. METHODS: After incubation of the MSCs in serum-free medium with/without 150 µM DFS for 48 h, the contents of N-CM and DFS-CM were analyzed by enzyme-linked immunosorbent assay. Diabetes (D) was induced by single dose of 55 mg/kg streptozotocin. Therapeutic effects of CMs were evaluated by biochemical, physical, histopathological and immunohistochemical analysis. RESULTS: The concentrations of vascular endothelial growth factor alpha, nerve growth factor and glial-derived neurotrophic factor in DFS-CM increased, while one of brain-derived neurotrophic factor decreased in comparison with N-CM. The creatinine clearance rate increased significantly in both treatment groups, while the improvement in albumin/creatinine ratio and renal mass index values were only significant for D + DFS-CM group. Light and electron microscopic deteriorations and loss of podocytes-specific nephrin and Wilms tumor-1 (WT-1) expressions were significantly restored in both treatment groups. Tubular beclin-1 expression was significantly increased for DN group, but it decreased in both treatment groups. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive apoptotic cell death increased in the tubules of D group, while it was only significantly decreased for D + DFS-CM group. CONCLUSIONS: DFS-CM can be more effective in the treatment of DN by reducing podocyte damage and tubular apoptotic cell death and regulating autophagic activity with its more concentrated secretome content than N-CM. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03121-6. BioMed Central 2022-09-02 /pmc/articles/PMC9438289/ /pubmed/36056427 http://dx.doi.org/10.1186/s13287-022-03121-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ozkan, Serbay
Isildar, Basak
Ercin, Merve
Gezginci-Oktayoglu, Selda
Konukoglu, Dildar
Neşetoğlu, Neşet
Oncul, Mahmut
Koyuturk, Meral
Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model
title Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model
title_full Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model
title_fullStr Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model
title_full_unstemmed Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model
title_short Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model
title_sort therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438289/
https://www.ncbi.nlm.nih.gov/pubmed/36056427
http://dx.doi.org/10.1186/s13287-022-03121-6
work_keys_str_mv AT ozkanserbay therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel
AT isildarbasak therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel
AT ercinmerve therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel
AT gezgincioktayogluselda therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel
AT konukogludildar therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel
AT nesetogluneset therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel
AT onculmahmut therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel
AT koyuturkmeral therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel